Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Kidney Disease: full-pipeline trial registry
32 of 103 indexed Chronic Kidney Disease trials are currently recruiting.
Corpus placement: #130 of 28,707 conditions by registered trial count.
103 US clinical trials · 32 currently recruiting · #130 of 28,707 conditions by registered trial count
Chronic Kidney Disease: 103 US clinical trials tracked, 32 recruiting.
Chronic Kidney Disease is the subject of 103 registered US clinical trials on ClinicalTrials.gov, 32 of them currently open to new participants. 27 are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most active sponsor is Bayer, running 8 of these trials.
Enrollment posture brief
Registry condition chronic-kidney-disease
OPEN 32 | RECR 31% | LATE 27 | EARLY 27 | RANK #130 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Eosinophilic Esophagitis (31% recruiting · 45 trials)
Chronic Kidney Disease lists 32 open slots (31% of 103 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Kidney Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Kidney Disease is recruiting below its size-band peers.
32 of 103 indexed trials (31.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Chronic Kidney Disease trials is spread across many organizations.
Bayer accounts for 8 of 103 trials (7.8%). 68 distinct sponsors appear on at least one study for this condition label.
-
Typical Chronic Kidney Disease enrolment sits around 124 participants.
Median target enrolment is 124 among the 102 trials that report a genuine target (sentinel values excluded). 43 of those (42.2%) plan for fewer than 100 participants.
-
Chronic Kidney Disease research is mostly interventional.
82 interventional and 21 observational studies make up this index (79.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
103 total, page 2 of 3
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)
Minneapolis Veterans Affairs Medical Center
NCT01446029
Is There a Digital Divide in Chronic Kidney Disease (CKD)?
Duke University
NCT03067779
Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) Patients
Dynavax Technologies Corporation
NCT00985426
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
Abbott
NCT00421733
Palm Tocotrienols in Chronic Hemodialysis (USA)
Wayne State University
NCT02358967
Diabetes CKD Lifestyle Technology Study
NYU Langone Health
NCT02266823
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
Bayer
NCT05901831
Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
Biogen
NCT00811889
20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
Akebia Therapeutics
NCT01906489
Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
Denver Nephrologists, P.C.
NCT02492620
Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
Takeda
NCT01478971
A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease
Denver Nephrologists, P.C.
NCT01475760
Study of Phosphate Levels in Patients With Chronic Kidney Disease
Vifor Pharma
NCT00824460
Vitamin D and Arterial Function in Patients With Chronic Kidney Disease
University of Colorado, Denver
NCT01384539
Metformin in Kidney Disease
VA Office of Research and Development
NCT02252081
DyeVert™ Plus Contrast Reduction System Multicenter Observational Study
Osprey Medical
NCT03715452
A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
Novo Nordisk A/S
NCT04865770
Sit Less, Interact, Move More (SLIMM) Intervention for Sedentary Behavior in Chronic Kidney Disease (CKD)
Srinvasan Beddhu
NCT02970123
A Video Decision Support Tool to Assist Elderly Patients in ESRD Treatment Decision-making
Massachusetts General Hospital
NCT02698722
Trial to Optimize Mineral Outcomes in Dialysis Patients
University of Colorado, Denver
NCT01100723
Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
ZS Pharma
NCT01493024
Endothelial Microparticles: A Novel Marker of Vascular Dysfunction
University of Colorado, Denver
NCT02230202
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
Prokidney
NCT02836574
Phosphate Lowering in CKD Trial
VA Office of Research and Development
NCT02209636
Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)
Vanderbilt University
NCT00308971
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
University of Alabama at Birmingham
NCT02888171
A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis
Novartis Pharmaceuticals
NCT00750295
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
Baylor Research Institute
NCT02251431
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Geisinger Clinic
NCT03015480
Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo
Amy Barton Pai
NCT00915876
Hemodialysis Vascular Access Imaging Study
Renal Research Institute
NCT02374762
Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
University of Alabama at Birmingham
NCT01988116
Rifaximin Therapy in Chronic Kidney Disease
Jason Stubbs, MD
NCT02342639
Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects
Atlanta VA Medical Center
NCT00427037
Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD
University of Colorado, Denver
NCT04600323
FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.
FAST BioMedical
NCT01978314
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
DiaMedica Therapeutics
NCT03795389
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
Kenneth R. Phelps, M.D.
NCT01191762
Advanced Glycation End-products, Inflammation and Vascular Health in Chronic Kidney Disease
University of Alabama at Birmingham
NCT01769963
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
University of Washington
NCT00552409
Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
University of Alabama at Birmingham
NCT02497300
Multicultural Healthy Diet in Chronic Kidney Disease
Montefiore Medical Center
NCT05504850
A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease
Renibus Therapeutics
NCT04072432
Analysis of Calcium Balance in Chronic Kidney Disease
University of Colorado, Denver
NCT00974532
The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease Patients
University of Florida
NCT01842087
Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease
Geoffrey Block
NCT01341678
Effects of Constipation Treatment in Chronic Kidney Disease: A Pilot Feasibility Trial
University of Tennessee
NCT06123195
Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease
University of California, Irvine
NCT00793806
Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study
University of Michigan
NCT00396123
A Trial of Doxycycline in Renal Disease
University of California, San Francisco
NCT02753426
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 17 |
| Phase 3 | 19 |
| Phase 4 | 8 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Kidney Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Kidney Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Kidney Disease page
103 registered trials, 32 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 32 Chronic Kidney Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Bayer sponsors the most Chronic Kidney Disease trials on record, review their full trial history before evaluating a specific study. See Bayer's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Kidney Disease condition card totals 103 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.